News and Events
Peptide therapies could disable coronavirus’ spike proteins
SQI investigators are collaborating with researchers from the Massachusetts Institute of Technology to develop new peptide therapies for targeting and disabling the coronavirus’ so-called “spike proteins," which attach to and infect healthy cells. SQI scientists involved in the project include SQI director Samuel Stupp, Peptide Synthesis Core director Mark Karver, assistant core scientist Suvendu Biswas, and Ruomeng Qiu, a graduate student in the Stupp group. Read the full story.
About SQI Events
Find out about events organized by SQI. Our institute hosts conferences and speakers related to bio-inspired science and technology and the work our researchers are performing.